Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TUR | -<0.01% | $164.05M | 0.59% |
BBUS | -<0.01% | $5.05B | 0.02% |
QDPL | 0.01% | $1.04B | 0.6% |
VXF | 0.01% | $22.53B | 0.05% |
VOTE | 0.02% | $823.50M | 0.05% |
XT | -0.03% | $3.43B | 0.46% |
LCTU | -0.03% | $1.28B | 0.14% |
EWY | -0.05% | $4.97B | 0.59% |
SWAN | 0.06% | $250.91M | 0.49% |
SCHK | -0.08% | $4.33B | 0.03% |
JEMA | 0.10% | $1.22B | 0.34% |
ESGU | -0.11% | $13.75B | 0.15% |
SCHX | -0.12% | $56.19B | 0.03% |
SPSK | -0.13% | $325.70M | 0.5% |
EMXC | -0.19% | $13.70B | 0.25% |
PBUS | 0.20% | $8.13B | 0.04% |
IJK | -0.23% | $8.93B | 0.17% |
CGXU | 0.26% | $3.76B | 0.54% |
DEHP | -0.27% | $265.80M | 0.41% |
ILCB | 0.27% | $1.06B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IHE | 60.48% | $551.02M | 0.39% |
IYK | 59.72% | $1.44B | 0.4% |
PPH | 59.08% | $584.35M | 0.36% |
HDV | 57.10% | $11.21B | 0.08% |
LVHD | 56.80% | $568.15M | 0.27% |
XLV | 54.69% | $34.17B | 0.09% |
XLP | 53.95% | $16.01B | 0.09% |
KXI | 53.41% | $853.43M | 0.41% |
IXJ | 53.35% | $3.75B | 0.41% |
SPHD | 53.26% | $3.21B | 0.3% |
FTXG | 52.92% | $22.44M | 0.6% |
SPLV | 52.01% | $7.63B | 0.25% |
IYH | 52.00% | $2.72B | 0.39% |
FHLC | 51.08% | $2.43B | 0.084% |
FDL | 50.73% | $5.60B | 0.43% |
VHT | 50.72% | $15.34B | 0.09% |
DHS | 50.47% | $1.25B | 0.38% |
FSTA | 50.10% | $1.35B | 0.084% |
VDC | 49.38% | $7.63B | 0.09% |
SDY | 47.90% | $20.31B | 0.35% |
Yahoo
STORY: From a crucial U.S. inflation reading to GDP figures from China, these are the stories to watch in business and finance in the coming week.:: Look Ahead:: Tariff testJune’s consumer price index, due on Tuesday, will offer Wall Street clues on when the Federal Reserve may next cut interest rates.Recent minutes from the Fed’s June meeting showed most officials remain worried about inflationary pressure they expect from Trump’s tariffs.Fed fund futures indicate a slim chance of a rate cut at the end of July meeting, but suggest easing in September is likely.It comes as corporate reports in the first earnings quarter under these tariff wars are due.Major banks like JPMorgan Chase, Bank of America and Wells Fargo will report in the coming week.Results from Netflix, Johnson & Johnson and 3M are also expected.:: Europe’s second-quarter earningsSecond-quarter earnings also kick off in Europe.STOXX 600 earnings are expected to fall 0.2% after last quarter’s 2.2% growth.Forward guidance will be key to understanding the fallout from this era of tariffs and fears of more levies.Though it's not obvious when looking at market performance: the S&P 500 is scaling new record highs and bourses in Europe – including Frankfurt and London – are hovering near previous peaks.:: Stimulating spendingChina’s GDP figures due on Tuesday are tipped to show the economy still chugging along above the government’s soft target of 5%-ish growth.But same-day retail sales numbers should reinforce that consumers are still saving instead of spending, frustrating government efforts to gear the economy towards consumption.With the politburo due to meet around the end of the month, hopes are high for more stimulus to come.:: A test of relevanceG20 finance ministers and central bankers gather in South Africa’s Durban starting on Thursday.The meeting comes amid growing questions over the group’s effectiveness on stalled progress on debt relief, climate finance and access to capital for developing nations.U.S. Treasury Secretary Scott Bessent will skip the gathering.
Yahoo
The pharmaceutical industry is staring down a major patent cliff, with key drugs from Merck (MRK), Bristol Myers Squibb (BMY), and Johnson & Johnson (JNJ) set to lose exclusivity by 2030. Yahoo Finance Senior Reporter Anjalee Khemlani and Freedom Capital Markets chief global strategist Jay Woods join Market Domination host Josh Lipton to discuss the industry's risks and how Wall Street is responding. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
Yahoo
Pre-Markets Red on Trump's Tariff Threats to Canada.
Yahoo
President Trump announced a new +35% tariff on all Canadian goods imported to the U.S. this morning. Pre-markets are now in the red.
Yahoo
BAYRY secures first global approval for Lynkuet in the UK, a hormone-free treatment for menopause-related hot flashes.
Yahoo
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Johnson & Johnson (JNJ), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ED | 56.28% | $36.42B | +10.51% | 3.36% |
NVS | 55.64% | $234.79B | +11.97% | 3.25% |
EXC | 53.21% | $44.05B | +23.53% | 3.60% |
SO | 53.19% | $102.50B | +16.78% | 3.13% |
KO | 53.17% | $300.31B | +10.57% | 2.87% |
DUK | 53.15% | $91.85B | +13.12% | 3.57% |
ES | 52.66% | $24.29B | +11.30% | 4.48% |
AWK | 52.64% | $27.82B | +4.74% | 2.18% |
CMS | 52.62% | $21.10B | +16.29% | 3.01% |
WEC | 52.54% | $33.73B | +31.54% | 3.27% |
GSK | 52.41% | $80.01B | +1.75% | 4.17% |
ABT | 52.22% | $232.44B | +28.24% | 1.71% |
PNW | 51.92% | $10.91B | +14.16% | 3.93% |
O | 51.71% | $51.41B | +3.51% | 5.62% |
AEP | 51.54% | $56.65B | +16.73% | 3.49% |
POR | 51.35% | $4.54B | -7.00% | 4.91% |
PFE | 51.20% | $146.57B | -10.05% | 6.62% |
WTRG | 50.72% | $10.52B | -6.15% | 3.49% |
DTE | 50.47% | $27.74B | +18.10% | 3.23% |
CPB | 50.01% | $9.09B | -32.74% | 5.09% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
YALA | <0.01% | $996.02M | +59.28% | 0.00% |
ALGN | -0.01% | $14.82B | -20.22% | 0.00% |
LFUS | 0.01% | $5.88B | -9.49% | 1.19% |
JXN | 0.01% | $6.28B | +13.13% | 3.45% |
AU | -0.02% | $23.43B | +60.17% | 2.22% |
SLQT | -0.02% | $417.98M | -34.77% | 0.00% |
DCGO | 0.02% | $148.66M | -50.66% | 0.00% |
NOAH | 0.03% | $805.53M | +50.31% | 9.69% |
VAL | 0.05% | $3.59B | -33.03% | 0.00% |
STVN | 0.05% | $7.08B | +23.82% | 0.24% |
BAH | 0.06% | $13.36B | -31.41% | 1.98% |
HGV | -0.06% | $4.40B | +13.83% | 0.00% |
PLL | -0.07% | $159.22M | -35.28% | 0.00% |
BV | -0.07% | $1.48B | +19.97% | 0.00% |
IRMD | 0.07% | $756.17M | +27.81% | 1.08% |
EH | 0.08% | $904.85M | +12.79% | 0.00% |
APRE | -0.08% | $9.79M | -55.86% | 0.00% |
OGI | -0.10% | $196.81M | -13.53% | 0.00% |
BNED | -0.11% | $391.62M | +39.39% | 0.00% |
INFU | -0.11% | $129.84M | -9.90% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
QFLR | -24.61% | $298.25M | 0.89% |
FFOG | -22.66% | $147.61M | 0.55% |
SMH | -22.65% | $27.29B | 0.35% |
MAGS | -21.76% | $2.31B | 0.29% |
WTAI | -21.59% | $213.53M | 0.45% |
CLSE | -21.47% | $185.65M | 1.44% |
PSI | -21.33% | $738.81M | 0.56% |
YMAG | -20.75% | $354.75M | 1.12% |
IYW | -20.59% | $21.87B | 0.39% |
FBY | -20.38% | $176.81M | 1.06% |
IGPT | -20.35% | $480.77M | 0.58% |
IGM | -20.35% | $6.73B | 0.41% |
AIPI | -19.98% | $326.97M | 0.65% |
ARTY | -19.88% | $1.12B | 0.47% |
FBCG | -19.80% | $4.40B | 0.59% |
SOXQ | -19.51% | $501.87M | 0.19% |
VGT | -19.13% | $95.46B | 0.09% |
FTEC | -19.03% | $14.17B | 0.084% |
SIXG | -18.83% | $644.63M | 0.3% |
IXN | -18.66% | $5.58B | 0.41% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TLN | -35.60% | $12.18B | +104.46% | 0.00% |
VRT | -34.43% | $46.01B | +30.00% | 0.11% |
NVDA | -32.77% | $4.00T | +28.81% | 0.02% |
ANET | -31.95% | $133.49B | +18.23% | 0.00% |
STRL | -30.69% | $7.19B | +101.60% | 0.00% |
VST | -29.81% | $66.43B | +113.71% | 0.46% |
EME | -29.73% | $24.51B | +45.85% | 0.18% |
CRDO | -29.69% | $16.70B | +217.32% | 0.00% |
CLS | -29.52% | $18.26B | +167.03% | 0.00% |
GEV | -28.52% | $147.21B | +205.24% | 0.05% |
ETN | -28.35% | $139.94B | +8.76% | 1.11% |
MOD | -28.03% | $4.85B | -14.60% | 0.00% |
FIX | -27.59% | $18.83B | +67.29% | 0.28% |
CAMT | -26.90% | $4.08B | -30.82% | 0.00% |
LITE | -26.66% | $6.43B | +61.56% | 0.00% |
AVGO | -26.42% | $1.30T | +61.43% | 0.84% |
PWR | -26.29% | $56.33B | +43.90% | 0.10% |
IESC | -25.89% | $6.16B | +102.02% | 0.00% |
POWL | -25.45% | $2.57B | +49.21% | 0.51% |
APH | -25.42% | $118.92B | +41.39% | 0.67% |
Double maintains 14 strategies that include JNJ - Johnson & Johnson
Current Value
$157.091 Year Return
Current Value
$157.091 Year Return